High Molecular Response With Lenalidomide, Rituximab in Untreated Follicular Lymphoma
Researchers for the RELEVANCE study measured MRD in a subset of patients to compare the molecular response of patients receiving R2 vs R-chemo.
Patricia Chaney
Patricia Chaney is a freelance writer specializing in the healthcare industry. She has 15 years of experience writing for providers, patients and other healthcare stakeholders. Her work has appeared on numerous health system websites and in industry journals.
